Posts

Showing posts from February, 2019

Generic Version of Adcirca to be Launched in US Under Brand Name ALYQ for PAH - Pulmonary Hypertension News

Generic Version of Adcirca to be Launched in US Under Brand Name ALYQ for PAH    Pulmonary Hypertension News Teva is launching a generic version of Adcirca (tadalafil) in the United States under the brand name ALYQ for the treatment of PAH.

Generic Version of Adcirca to be Launched in US Under Brand Name ALYQ for PAH - Pulmonary Hypertension News

Generic Version of Adcirca to be Launched in US Under Brand Name ALYQ for PAH    Pulmonary Hypertension News Teva is launching a generic version of Adcirca (tadalafil) in the United States under the brand name ALYQ for the treatment of PAH.

Generic Version of Adcirca to be Launched in US Under Brand Name ALYQ for PAH - Pulmonary Hypertension News

Generic Version of Adcirca to be Launched in US Under Brand Name ALYQ for PAH    Pulmonary Hypertension News Teva is launching a generic version of Adcirca (tadalafil) in the United States under the brand name ALYQ for the treatment of PAH.

Generic Version of Adcirca to be Launched in US Under Brand Name ALYQ for PAH - Pulmonary Hypertension News

Generic Version of Adcirca to be Launched in US Under Brand Name ALYQ for PAH    Pulmonary Hypertension News Teva is launching a generic version of Adcirca (tadalafil) in the United States under the brand name ALYQ for the treatment of PAH.

Generic Version of Adcirca to be Launched in US Under Brand Name ALYQ for PAH - Pulmonary Hypertension News

Generic Version of Adcirca to be Launched in US Under Brand Name ALYQ for PAH    Pulmonary Hypertension News Teva is launching a generic version of Adcirca (tadalafil) in the United States under the brand name ALYQ for the treatment of PAH.

Generic Version of Adcirca to be Launched in US Under Brand Name ALYQ for PAH - Pulmonary Hypertension News

Generic Version of Adcirca to be Launched in US Under Brand Name ALYQ for PAH    Pulmonary Hypertension News Teva is launching a generic version of Adcirca (tadalafil) in the United States under the brand name ALYQ for the treatment of PAH.

Quantitative CT assessment of bronchial and vascular alterations in se | COPD - Dove Medical Press

Quantitative CT assessment of bronchial and vascular alterations in se | COPD    Dove Medical Press Florence Coste,1,2,* Ilyes Benlala,1,2,* Gaël Dournes,1–3 Claire Dromer,3 Elodie Blanchard,3 Pierre-Olivier Girodet,1–3 Michel Montaudon,1–3 Fabien ...

Quantitative CT assessment of bronchial and vascular alterations in se | COPD - Dove Medical Press

Quantitative CT assessment of bronchial and vascular alterations in se | COPD    Dove Medical Press Florence Coste,1,2,* Ilyes Benlala,1,2,* Gaël Dournes,1–3 Claire Dromer,3 Elodie Blanchard,3 Pierre-Olivier Girodet,1–3 Michel Montaudon,1–3 Fabien ...

Expressing Gratitude Instead of Apologizing - Pulmonary Hypertension News

Expressing Gratitude Instead of Apologizing    Pulmonary Hypertension News Columnist and forums moderator Brittany Foster explains how contantly apologizing made her mental health suffer. She now replaces apologies with gratitude.

Early Results on Rodatristat Ethyl Support Launch of Phase 2 Trial in PAH Patients - Pulmonary Hypertension News

Early Results on Rodatristat Ethyl Support Launch of Phase 2 Trial in PAH Patients    Pulmonary Hypertension News Preclinical and early clinical data showing the safety and potential therapeutic activity of rodatristat ethyl support its progression into Phase 2 trials in patients ...

Group Publishes New Guidelines on Home Oxygen Therapy for Kids with PH - Pulmonary Hypertension News

Group Publishes New Guidelines on Home Oxygen Therapy for Kids with PH    Pulmonary Hypertension News The American Thoracic Society issued guidelines for home oxygen therapy to treat chronic hypoxemia in children with pulmonary hypertension.

Should Macitentan Plus Riociguat Be Used as First-Line Therapy in PAH? - Pulmonology Advisor

Should Macitentan Plus Riociguat Be Used as First-Line Therapy in PAH?    Pulmonology Advisor Upfront combination therapy with macitentan plus riociguat has demonstrated effectiveness in patients with pulmonary arterial hypertension.

Group Publishes Guidelines for Home Oxygen Therapy Use in Children - Cystic Fibrosis News Today

Group Publishes Guidelines for Home Oxygen Therapy Use in Children    Cystic Fibrosis News Today The American Thoracic Society published recommendations by a panel of experts on the use of home oxygen therapy in children with CF and other illnesses.

Investigation: Woman's tragic death among 68 at HRRJ since 2003 - WAVY-TV

Investigation: Woman's tragic death among 68 at HRRJ since 2003    WAVY-TV 10 On Your Side is investigating what changes are being made at Hampton Roads Regional Jail.

New clinical practice guideline on home oxygen therapy for children - News-Medical.net

New clinical practice guideline on home oxygen therapy for children    News-Medical.net The American Thoracic Society has developed a new clinical practice guideline for home oxygen therapy for children. The guideline appears in the Feb.

Expressing Gratitude Instead of Apologizing - Pulmonary Hypertension News

Expressing Gratitude Instead of Apologizing    Pulmonary Hypertension News Columnist and forums moderator Brittany Foster explains how contantly apologizing made her mental health suffer. She now replaces apologies with gratitude.

Reduced Right Ventricular Output Reserve Observed in SSc With Elevated PAP - Rheumatology Advisor

Reduced Right Ventricular Output Reserve Observed in SSc With Elevated PAP    Rheumatology Advisor Patients with systemic sclerosis (SSc) with mildly elevated resting mean pulmonary artery pressure (PAP) appear to have reduced right ventricular (RV) output ...

Generic Version of Adcirca to be Launched in US Under Brand Name ALYQ for PAH - Pulmonary Hypertension News

Generic Version of Adcirca to be Launched in US Under Brand Name ALYQ for PAH    Pulmonary Hypertension News Teva is launching a generic version of Adcirca (tadalafil) in the United States under the brand name ALYQ for the treatment of PAH.

Early Results on Rodatristat Ethyl Support Launch of Phase 2 Trial in PAH Patients - Pulmonary Hypertension News

Early Results on Rodatristat Ethyl Support Launch of Phase 2 Trial in PAH Patients    Pulmonary Hypertension News Preclinical and early clinical data showing the safety and potential therapeutic activity of rodatristat ethyl support its progression into Phase 2 trials in patients ...

Group Publishes New Guidelines on Home Oxygen Therapy for Kids with PH - Pulmonary Hypertension News

Group Publishes New Guidelines on Home Oxygen Therapy for Kids with PH    Pulmonary Hypertension News The American Thoracic Society issued guidelines for home oxygen therapy to treat chronic hypoxemia in children with pulmonary hypertension.

Should Macitentan Plus Riociguat Be Used as First-Line Therapy in PAH? - Pulmonology Advisor

Should Macitentan Plus Riociguat Be Used as First-Line Therapy in PAH?    Pulmonology Advisor Upfront combination therapy with macitentan plus riociguat has demonstrated effectiveness in patients with pulmonary arterial hypertension.

Reduced Right Ventricular Output Reserve Observed in SSc With Elevated PAP - Rheumatology Advisor

Reduced Right Ventricular Output Reserve Observed in SSc With Elevated PAP    Rheumatology Advisor Patients with systemic sclerosis (SSc) with mildly elevated resting mean pulmonary artery pressure (PAP) appear to have reduced right ventricular (RV) output ...

Pulmonary Hypertension Drug Market: Report Provides Growing Demand for Developing Economics - DD News Herald

Pulmonary Hypertension Drug Market: Report Provides Growing Demand for Developing Economics    DD News Herald This press release contains short but detailed information on “Pulmonary Hypertension Drug Market” which provides the all the answers related to the industrial ...

Generic Version of Adcirca to be Launched in US Under Brand Name ALYQ for PAH - Pulmonary Hypertension News

Generic Version of Adcirca to be Launched in US Under Brand Name ALYQ for PAH    Pulmonary Hypertension News Teva is launching a generic version of Adcirca (tadalafil) in the United States under the brand name ALYQ for the treatment of PAH.

Early Results on Rodatristat Ethyl Support Launch of Phase 2 Trial in PAH Patients - Pulmonary Hypertension News

Early Results on Rodatristat Ethyl Support Launch of Phase 2 Trial in PAH Patients    Pulmonary Hypertension News Preclinical and early clinical data showing the safety and potential therapeutic activity of rodatristat ethyl support its progression into Phase 2 trials in patients ...

Group Publishes New Guidelines on Home Oxygen Therapy for Kids with PH - Pulmonary Hypertension News

Group Publishes New Guidelines on Home Oxygen Therapy for Kids with PH    Pulmonary Hypertension News The American Thoracic Society issued guidelines for home oxygen therapy to treat chronic hypoxemia in children with pulmonary hypertension.

Should Macitentan Plus Riociguat Be Used as First-Line Therapy in PAH? - Pulmonology Advisor

Should Macitentan Plus Riociguat Be Used as First-Line Therapy in PAH?    Pulmonology Advisor Upfront combination therapy with macitentan plus riociguat has demonstrated effectiveness in patients with pulmonary arterial hypertension.

Reduced Right Ventricular Output Reserve Observed in SSc With Elevated PAP - Rheumatology Advisor

Reduced Right Ventricular Output Reserve Observed in SSc With Elevated PAP    Rheumatology Advisor Patients with systemic sclerosis (SSc) with mildly elevated resting mean pulmonary artery pressure (PAP) appear to have reduced right ventricular (RV) output ...

Toronto Partnership to Create Fast Diagnostic Tools to Assess Donated Lungs for Transplant - Pulmonary Hypertension News

Toronto Partnership to Create Fast Diagnostic Tools to Assess Donated Lungs for Transplant    Pulmonary Hypertension News SQI Diagnostics and Toronto's University Health Network plan to create rapid diagnostic tools to assess lung suitability for transplant.

Reduced Right Ventricular Output Reserve Observed in SSc With Elevated PAP - Rheumatology Advisor

Reduced Right Ventricular Output Reserve Observed in SSc With Elevated PAP    Rheumatology Advisor Patients with systemic sclerosis (SSc) with mildly elevated resting mean pulmonary artery pressure (PAP) appear to have reduced right ventricular (RV) output ...

Prevalence of pulmonary hypertension in systemic sclerosis | The Journal of Rheumatology - MD Linx

Prevalence of pulmonary hypertension in systemic sclerosis | The Journal of Rheumatology    MD Linx Internal Medicine Article: Risk factors for mortality and cardiopulmonary hospitalization in systemic sclerosis patients at risk for pulmonary hypertension, in the ...

Teva launches generic pulmonary hypertension drug - Globes

Teva launches generic pulmonary hypertension drug    Globes Teva EVP: This launch is an important addition to our portfolio of generic medicines that treat complex conditions.

CHEST Provides PAH Adult Treatment Guideline Updates - MD Magazine

CHEST Provides PAH Adult Treatment Guideline Updates    MD Magazine The organization has provided five-year updates to its recommendation of therapies for adults with pulmonary arterial hypertension.

Group Publishes New Guidelines on Home Oxygen Therapy for Kids with PH - Pulmonary Hypertension News

Group Publishes New Guidelines on Home Oxygen Therapy for Kids with PH    Pulmonary Hypertension News The American Thoracic Society issued guidelines for home oxygen therapy to treat chronic hypoxemia in children with pulmonary hypertension.

Toronto Partnership to Create Fast Diagnostic Tools to Assess Donated Lungs for Transplant - Pulmonary Hypertension News

Toronto Partnership to Create Fast Diagnostic Tools to Assess Donated Lungs for Transplant    Pulmonary Hypertension News SQI Diagnostics and Toronto's University Health Network plan to create rapid diagnostic tools to assess lung suitability for transplant.

Should Macitentan Plus Riociguat Be Used as First-Line Therapy in PAH? - Pulmonology Advisor

Should Macitentan Plus Riociguat Be Used as First-Line Therapy in PAH?    Pulmonology Advisor Upfront combination therapy with macitentan plus riociguat has demonstrated effectiveness in patients with pulmonary arterial hypertension.

Early Results on Rodatristat Ethyl Support Launch of Phase 2 Trial in PAH Patients - Pulmonary Hypertension News

Early Results on Rodatristat Ethyl Support Launch of Phase 2 Trial in PAH Patients    Pulmonary Hypertension News Preclinical and early clinical data showing the safety and potential therapeutic activity of rodatristat ethyl support its progression into Phase 2 trials in patients ...

Reduced Right Ventricular Output Reserve Observed in SSc With Elevated PAP - Rheumatology Advisor

Reduced Right Ventricular Output Reserve Observed in SSc With Elevated PAP    Rheumatology Advisor Patients with systemic sclerosis (SSc) with mildly elevated resting mean pulmonary artery pressure (PAP) appear to have reduced right ventricular (RV) output ...

Prevalence of pulmonary hypertension in systemic sclerosis | The Journal of Rheumatology - MD Linx

Prevalence of pulmonary hypertension in systemic sclerosis | The Journal of Rheumatology    MD Linx Internal Medicine Article: Risk factors for mortality and cardiopulmonary hospitalization in systemic sclerosis patients at risk for pulmonary hypertension, in the ...

Teva launches generic pulmonary hypertension drug - Globes

Teva launches generic pulmonary hypertension drug    Globes Teva EVP: This launch is an important addition to our portfolio of generic medicines that treat complex conditions.

CHEST Provides PAH Adult Treatment Guideline Updates - MD Magazine

CHEST Provides PAH Adult Treatment Guideline Updates    MD Magazine The organization has provided five-year updates to its recommendation of therapies for adults with pulmonary arterial hypertension.

Group Publishes New Guidelines on Home Oxygen Therapy for Kids with PH - Pulmonary Hypertension News

Group Publishes New Guidelines on Home Oxygen Therapy for Kids with PH    Pulmonary Hypertension News The American Thoracic Society issued guidelines for home oxygen therapy to treat chronic hypoxemia in children with pulmonary hypertension.

Toronto Partnership to Create Fast Diagnostic Tools to Assess Donated Lungs for Transplant - Pulmonary Hypertension News

Toronto Partnership to Create Fast Diagnostic Tools to Assess Donated Lungs for Transplant    Pulmonary Hypertension News SQI Diagnostics and Toronto's University Health Network plan to create rapid diagnostic tools to assess lung suitability for transplant.

Should Macitentan Plus Riociguat Be Used as First-Line Therapy in PAH? - Pulmonology Advisor

Should Macitentan Plus Riociguat Be Used as First-Line Therapy in PAH?    Pulmonology Advisor Upfront combination therapy with macitentan plus riociguat has demonstrated effectiveness in patients with pulmonary arterial hypertension.

Early Results on Rodatristat Ethyl Support Launch of Phase 2 Trial in PAH Patients - Pulmonary Hypertension News

Early Results on Rodatristat Ethyl Support Launch of Phase 2 Trial in PAH Patients    Pulmonary Hypertension News Preclinical and early clinical data showing the safety and potential therapeutic activity of rodatristat ethyl support its progression into Phase 2 trials in patients ...

Reduced Right Ventricular Output Reserve Observed in SSc With Elevated PAP - Rheumatology Advisor

Reduced Right Ventricular Output Reserve Observed in SSc With Elevated PAP    Rheumatology Advisor Patients with systemic sclerosis (SSc) with mildly elevated resting mean pulmonary artery pressure (PAP) appear to have reduced right ventricular (RV) output ...

Prevalence of pulmonary hypertension in systemic sclerosis | The Journal of Rheumatology - MD Linx

Prevalence of pulmonary hypertension in systemic sclerosis | The Journal of Rheumatology    MD Linx Internal Medicine Article: Risk factors for mortality and cardiopulmonary hospitalization in systemic sclerosis patients at risk for pulmonary hypertension, in the ...

Teva launches generic pulmonary hypertension drug - Globes

Teva launches generic pulmonary hypertension drug    Globes Teva EVP: This launch is an important addition to our portfolio of generic medicines that treat complex conditions.

CHEST Provides PAH Adult Treatment Guideline Updates - MD Magazine

CHEST Provides PAH Adult Treatment Guideline Updates    MD Magazine The organization has provided five-year updates to its recommendation of therapies for adults with pulmonary arterial hypertension.

Toronto Partnership to Create Fast Diagnostic Tools to Assess Donated Lungs for Transplant - Pulmonary Hypertension News

Toronto Partnership to Create Fast Diagnostic Tools to Assess Donated Lungs for Transplant    Pulmonary Hypertension News SQI Diagnostics and Toronto's University Health Network plan to create rapid diagnostic tools to assess lung suitability for transplant.

Should Macitentan Plus Riociguat Be Used as First-Line Therapy in PAH? - Pulmonology Advisor

Should Macitentan Plus Riociguat Be Used as First-Line Therapy in PAH?    Pulmonology Advisor Upfront combination therapy with macitentan plus riociguat has demonstrated effectiveness in patients with pulmonary arterial hypertension.

Group Publishes New Guidelines on Home Oxygen Therapy for Kids with PH - Pulmonary Hypertension News

Group Publishes New Guidelines on Home Oxygen Therapy for Kids with PH    Pulmonary Hypertension News The American Thoracic Society issued guidelines for home oxygen therapy to treat chronic hypoxemia in children with pulmonary hypertension.

Early Results on Rodatristat Ethyl Support Launch of Phase 2 Trial in PAH Patients - Pulmonary Hypertension News

Early Results on Rodatristat Ethyl Support Launch of Phase 2 Trial in PAH Patients    Pulmonary Hypertension News Preclinical and early clinical data showing the safety and potential therapeutic activity of rodatristat ethyl support its progression into Phase 2 trials in patients ...

Reduced Right Ventricular Output Reserve Observed in SSc With Elevated PAP - Rheumatology Advisor

Reduced Right Ventricular Output Reserve Observed in SSc With Elevated PAP    Rheumatology Advisor Patients with systemic sclerosis (SSc) with mildly elevated resting mean pulmonary artery pressure (PAP) appear to have reduced right ventricular (RV) output ...

Lung transplantation for idiopathic pulmonary fibrosis - The Lancet

Lung transplantation for idiopathic pulmonary fibrosis    The Lancet Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease with a poor prognosis. Lung transplantation is the only intervention shown to increase life ...

Prevalence of pulmonary hypertension in systemic sclerosis | The Journal of Rheumatology - MD Linx

Prevalence of pulmonary hypertension in systemic sclerosis | The Journal of Rheumatology    MD Linx Internal Medicine Article: Risk factors for mortality and cardiopulmonary hospitalization in systemic sclerosis patients at risk for pulmonary hypertension, in the ...

Teva launches generic pulmonary hypertension drug - Globes

Teva launches generic pulmonary hypertension drug    Globes Teva EVP: This launch is an important addition to our portfolio of generic medicines that treat complex conditions.

Toronto Partnership to Create Fast Diagnostic Tools to Assess Donated Lungs for Transplant - Pulmonary Hypertension News

Toronto Partnership to Create Fast Diagnostic Tools to Assess Donated Lungs for Transplant    Pulmonary Hypertension News SQI Diagnostics and Toronto's University Health Network plan to create rapid diagnostic tools to assess lung suitability for transplant.

Should Macitentan Plus Riociguat Be Used as First-Line Therapy in PAH? - Pulmonology Advisor

Should Macitentan Plus Riociguat Be Used as First-Line Therapy in PAH?    Pulmonology Advisor Upfront combination therapy with macitentan plus riociguat has demonstrated effectiveness in patients with pulmonary arterial hypertension.

Reduced Right Ventricular Output Reserve Observed in SSc With Elevated PAP - Rheumatology Advisor

Reduced Right Ventricular Output Reserve Observed in SSc With Elevated PAP    Rheumatology Advisor Patients with systemic sclerosis (SSc) with mildly elevated resting mean pulmonary artery pressure (PAP) appear to have reduced right ventricular (RV) output ...

Prevalence of pulmonary hypertension in systemic sclerosis | The Journal of Rheumatology - MD Linx

Prevalence of pulmonary hypertension in systemic sclerosis | The Journal of Rheumatology    MD Linx Internal Medicine Article: Risk factors for mortality and cardiopulmonary hospitalization in systemic sclerosis patients at risk for pulmonary hypertension, in the ...

Teva launches generic pulmonary hypertension drug - Globes

Teva launches generic pulmonary hypertension drug    Globes Teva EVP: This launch is an important addition to our portfolio of generic medicines that treat complex conditions.

Group Publishes New Guidelines on Home Oxygen Therapy for Kids with PH - Pulmonary Hypertension News

Group Publishes New Guidelines on Home Oxygen Therapy for Kids with PH    Pulmonary Hypertension News The American Thoracic Society issued guidelines for home oxygen therapy to treat chronic hypoxemia in children with pulmonary hypertension.

Should Macitentan Plus Riociguat Be Used as First-Line Therapy in PAH? - Pulmonology Advisor

Should Macitentan Plus Riociguat Be Used as First-Line Therapy in PAH?    Pulmonology Advisor Upfront combination therapy with macitentan plus riociguat has demonstrated effectiveness in patients with pulmonary arterial hypertension.

Early Results on Rodatristat Ethyl Support Launch of Phase 2 Trial in PAH Patients - Pulmonary Hypertension News

Early Results on Rodatristat Ethyl Support Launch of Phase 2 Trial in PAH Patients    Pulmonary Hypertension News Preclinical and early clinical data showing the safety and potential therapeutic activity of rodatristat ethyl support its progression into Phase 2 trials in patients ...

CHEST Provides PAH Adult Treatment Guideline Updates - MD Magazine

CHEST Provides PAH Adult Treatment Guideline Updates    MD Magazine The organization has provided five-year updates to its recommendation of therapies for adults with pulmonary arterial hypertension.

Investigation: Woman's tragic death among 68 at HRRJ since 2003 - WAVY-TV

Investigation: Woman's tragic death among 68 at HRRJ since 2003    WAVY-TV 10 On Your Side is investigating what changes are being made at Hampton Roads Regional Jail.

Toronto Partnership to Create Fast Diagnostic Tools to Assess Donated Lungs for Transplant - Pulmonary Hypertension News

Toronto Partnership to Create Fast Diagnostic Tools to Assess Donated Lungs for Transplant    Pulmonary Hypertension News SQI Diagnostics and Toronto's University Health Network plan to create rapid diagnostic tools to assess lung suitability for transplant.

Should Macitentan Plus Riociguat Be Used as First-Line Therapy in PAH? - Pulmonology Advisor

Should Macitentan Plus Riociguat Be Used as First-Line Therapy in PAH?    Pulmonology Advisor Upfront combination therapy with macitentan plus riociguat has demonstrated effectiveness in patients with pulmonary arterial hypertension.

Prevalence of pulmonary hypertension in systemic sclerosis | The Journal of Rheumatology - MD Linx

Prevalence of pulmonary hypertension in systemic sclerosis | The Journal of Rheumatology    MD Linx Internal Medicine Article: Risk factors for mortality and cardiopulmonary hospitalization in systemic sclerosis patients at risk for pulmonary hypertension, in the ...

Teva launches generic pulmonary hypertension drug - Globes

Teva launches generic pulmonary hypertension drug    Globes Teva EVP: This launch is an important addition to our portfolio of generic medicines that treat complex conditions.

Group Publishes New Guidelines on Home Oxygen Therapy for Kids with PH - Pulmonary Hypertension News

Group Publishes New Guidelines on Home Oxygen Therapy for Kids with PH    Pulmonary Hypertension News The American Thoracic Society issued guidelines for home oxygen therapy to treat chronic hypoxemia in children with pulmonary hypertension.

Toronto Partnership to Create Fast Diagnostic Tools to Assess Donated Lungs for Transplant - Pulmonary Hypertension News

Toronto Partnership to Create Fast Diagnostic Tools to Assess Donated Lungs for Transplant    Pulmonary Hypertension News SQI Diagnostics and Toronto's University Health Network plan to create rapid diagnostic tools to assess lung suitability for transplant.

Should Macitentan Plus Riociguat Be Used as First-Line Therapy in PAH? - Pulmonology Advisor

Should Macitentan Plus Riociguat Be Used as First-Line Therapy in PAH?    Pulmonology Advisor Upfront combination therapy with macitentan plus riociguat has demonstrated effectiveness in patients with pulmonary arterial hypertension.

Early Results on Rodatristat Ethyl Support Launch of Phase 2 Trial in PAH Patients - Pulmonary Hypertension News

Early Results on Rodatristat Ethyl Support Launch of Phase 2 Trial in PAH Patients    Pulmonary Hypertension News Preclinical and early clinical data showing the safety and potential therapeutic activity of rodatristat ethyl support its progression into Phase 2 trials in patients ...

Prevalence of pulmonary hypertension in systemic sclerosis | The Journal of Rheumatology - MD Linx

Prevalence of pulmonary hypertension in systemic sclerosis | The Journal of Rheumatology    MD Linx Internal Medicine Article: Risk factors for mortality and cardiopulmonary hospitalization in systemic sclerosis patients at risk for pulmonary hypertension, in the ...

Teva launches generic pulmonary hypertension drug - Globes

Teva launches generic pulmonary hypertension drug    Globes Teva EVP: This launch is an important addition to our portfolio of generic medicines that treat complex conditions.

Group Publishes New Guidelines on Home Oxygen Therapy for Kids with PH - Pulmonary Hypertension News

Group Publishes New Guidelines on Home Oxygen Therapy for Kids with PH    Pulmonary Hypertension News The American Thoracic Society issued guidelines for home oxygen therapy to treat chronic hypoxemia in children with pulmonary hypertension.

Toronto Partnership to Create Fast Diagnostic Tools to Assess Donated Lungs for Transplant - Pulmonary Hypertension News

Toronto Partnership to Create Fast Diagnostic Tools to Assess Donated Lungs for Transplant    Pulmonary Hypertension News SQI Diagnostics and Toronto's University Health Network plan to create rapid diagnostic tools to assess lung suitability for transplant.

Should Macitentan Plus Riociguat Be Used as First-Line Therapy in PAH? - Pulmonology Advisor

Should Macitentan Plus Riociguat Be Used as First-Line Therapy in PAH?    Pulmonology Advisor Upfront combination therapy with macitentan plus riociguat has demonstrated effectiveness in patients with pulmonary arterial hypertension.

Early Results on Rodatristat Ethyl Support Launch of Phase 2 Trial in PAH Patients - Pulmonary Hypertension News

Early Results on Rodatristat Ethyl Support Launch of Phase 2 Trial in PAH Patients    Pulmonary Hypertension News Preclinical and early clinical data showing the safety and potential therapeutic activity of rodatristat ethyl support its progression into Phase 2 trials in patients ...

Prevalence of pulmonary hypertension in systemic sclerosis | The Journal of Rheumatology - MD Linx

Prevalence of pulmonary hypertension in systemic sclerosis | The Journal of Rheumatology    MD Linx Internal Medicine Article: Risk factors for mortality and cardiopulmonary hospitalization in systemic sclerosis patients at risk for pulmonary hypertension, in the ...

Teva launches generic pulmonary hypertension drug - Globes

Teva launches generic pulmonary hypertension drug    Globes Teva EVP: This launch is an important addition to our portfolio of generic medicines that treat complex conditions.

Group Publishes New Guidelines on Home Oxygen Therapy for Kids with PH - Pulmonary Hypertension News

Group Publishes New Guidelines on Home Oxygen Therapy for Kids with PH    Pulmonary Hypertension News The American Thoracic Society issued guidelines for home oxygen therapy to treat chronic hypoxemia in children with pulmonary hypertension.

Toronto Partnership to Create Fast Diagnostic Tools to Assess Donated Lungs for Transplant - Pulmonary Hypertension News

Toronto Partnership to Create Fast Diagnostic Tools to Assess Donated Lungs for Transplant    Pulmonary Hypertension News SQI Diagnostics and Toronto's University Health Network plan to create rapid diagnostic tools to assess lung suitability for transplant.

Should Macitentan Plus Riociguat Be Used as First-Line Therapy in PAH? - Pulmonology Advisor

Should Macitentan Plus Riociguat Be Used as First-Line Therapy in PAH?    Pulmonology Advisor Upfront combination therapy with macitentan plus riociguat has demonstrated effectiveness in patients with pulmonary arterial hypertension.

Early Results on Rodatristat Ethyl Support Launch of Phase 2 Trial in PAH Patients - Pulmonary Hypertension News

Early Results on Rodatristat Ethyl Support Launch of Phase 2 Trial in PAH Patients    Pulmonary Hypertension News Preclinical and early clinical data showing the safety and potential therapeutic activity of rodatristat ethyl support its progression into Phase 2 trials in patients ...

Prevalence of pulmonary hypertension in systemic sclerosis | The Journal of Rheumatology - MD Linx

Prevalence of pulmonary hypertension in systemic sclerosis | The Journal of Rheumatology    MD Linx Internal Medicine Article: Risk factors for mortality and cardiopulmonary hospitalization in systemic sclerosis patients at risk for pulmonary hypertension, in the ...

Teva launches generic pulmonary hypertension drug - Globes

Teva launches generic pulmonary hypertension drug    Globes Teva EVP: This launch is an important addition to our portfolio of generic medicines that treat complex conditions.

Group Publishes New Guidelines on Home Oxygen Therapy for Kids with PH - Pulmonary Hypertension News

Group Publishes New Guidelines on Home Oxygen Therapy for Kids with PH    Pulmonary Hypertension News The American Thoracic Society issued guidelines for home oxygen therapy to treat chronic hypoxemia in children with pulmonary hypertension.

Toronto Partnership to Create Fast Diagnostic Tools to Assess Donated Lungs for Transplant - Pulmonary Hypertension News

Toronto Partnership to Create Fast Diagnostic Tools to Assess Donated Lungs for Transplant    Pulmonary Hypertension News SQI Diagnostics and Toronto's University Health Network plan to create rapid diagnostic tools to assess lung suitability for transplant.

Should Macitentan Plus Riociguat Be Used as First-Line Therapy in PAH? - Pulmonology Advisor

Should Macitentan Plus Riociguat Be Used as First-Line Therapy in PAH?    Pulmonology Advisor Upfront combination therapy with macitentan plus riociguat has demonstrated effectiveness in patients with pulmonary arterial hypertension.

Early Results on Rodatristat Ethyl Support Launch of Phase 2 Trial in PAH Patients - Pulmonary Hypertension News

Early Results on Rodatristat Ethyl Support Launch of Phase 2 Trial in PAH Patients    Pulmonary Hypertension News Preclinical and early clinical data showing the safety and potential therapeutic activity of rodatristat ethyl support its progression into Phase 2 trials in patients ...

Prevalence of pulmonary hypertension in systemic sclerosis | The Journal of Rheumatology - MD Linx

Prevalence of pulmonary hypertension in systemic sclerosis | The Journal of Rheumatology    MD Linx Internal Medicine Article: Risk factors for mortality and cardiopulmonary hospitalization in systemic sclerosis patients at risk for pulmonary hypertension, in the ...

Teva launches generic pulmonary hypertension drug - Globes

Teva launches generic pulmonary hypertension drug    Globes Teva EVP: This launch is an important addition to our portfolio of generic medicines that treat complex conditions.

Group Publishes New Guidelines on Home Oxygen Therapy for Kids with PH - Pulmonary Hypertension News

Group Publishes New Guidelines on Home Oxygen Therapy for Kids with PH    Pulmonary Hypertension News The American Thoracic Society issued guidelines for home oxygen therapy to treat chronic hypoxemia in children with pulmonary hypertension.

Toronto Partnership to Create Fast Diagnostic Tools to Assess Donated Lungs for Transplant - Pulmonary Hypertension News

Toronto Partnership to Create Fast Diagnostic Tools to Assess Donated Lungs for Transplant    Pulmonary Hypertension News SQI Diagnostics and Toronto's University Health Network plan to create rapid diagnostic tools to assess lung suitability for transplant.

Should Macitentan Plus Riociguat Be Used as First-Line Therapy in PAH? - Pulmonology Advisor

Should Macitentan Plus Riociguat Be Used as First-Line Therapy in PAH?    Pulmonology Advisor Upfront combination therapy with macitentan plus riociguat has demonstrated effectiveness in patients with pulmonary arterial hypertension.

Early Results on Rodatristat Ethyl Support Launch of Phase 2 Trial in PAH Patients - Pulmonary Hypertension News

Early Results on Rodatristat Ethyl Support Launch of Phase 2 Trial in PAH Patients    Pulmonary Hypertension News Preclinical and early clinical data showing the safety and potential therapeutic activity of rodatristat ethyl support its progression into Phase 2 trials in patients ...

Prevalence of pulmonary hypertension in systemic sclerosis | The Journal of Rheumatology - MD Linx

Prevalence of pulmonary hypertension in systemic sclerosis | The Journal of Rheumatology    MD Linx Internal Medicine Article: Risk factors for mortality and cardiopulmonary hospitalization in systemic sclerosis patients at risk for pulmonary hypertension, in the ...

Teva launches generic pulmonary hypertension drug - Globes

Teva launches generic pulmonary hypertension drug    Globes Teva EVP: This launch is an important addition to our portfolio of generic medicines that treat complex conditions.

Toronto Partnership to Create Fast Diagnostic Tools to Assess Donated Lungs for Transplant - Pulmonary Hypertension News

Toronto Partnership to Create Fast Diagnostic Tools to Assess Donated Lungs for Transplant    Pulmonary Hypertension News SQI Diagnostics and Toronto's University Health Network plan to create rapid diagnostic tools to assess lung suitability for transplant.

Should Macitentan Plus Riociguat Be Used as First-Line Therapy in PAH? - Pulmonology Advisor

Should Macitentan Plus Riociguat Be Used as First-Line Therapy in PAH?    Pulmonology Advisor Upfront combination therapy with macitentan plus riociguat has demonstrated effectiveness in patients with pulmonary arterial hypertension.

4,000th Lifesaving Heart and Lung Surgery at UC San Diego Health - UC San Diego Health

4,000th Lifesaving Heart and Lung Surgery at UC San Diego Health    UC San Diego Health UC San Diego Health performed its 4000th pulmonary thromboendarterectomy (PTE), a lifesaving surgery to clear the lung's arteries of scar-like tissue that robs ...

Toronto Partnership to Create Fast Diagnostic Tools to Assess Donated Lungs for Transplant - Pulmonary Hypertension News

Toronto Partnership to Create Fast Diagnostic Tools to Assess Donated Lungs for Transplant    Pulmonary Hypertension News SQI Diagnostics and Toronto's University Health Network plan to create rapid diagnostic tools to assess lung suitability for transplant.

Should Macitentan Plus Riociguat Be Used as First-Line Therapy in PAH? - Pulmonology Advisor

Should Macitentan Plus Riociguat Be Used as First-Line Therapy in PAH?    Pulmonology Advisor Upfront combination therapy with macitentan plus riociguat has demonstrated effectiveness in patients with pulmonary arterial hypertension.

4,000th Lifesaving Heart and Lung Surgery at UC San Diego Health - UC San Diego Health

4,000th Lifesaving Heart and Lung Surgery at UC San Diego Health    UC San Diego Health UC San Diego Health performed its 4000th pulmonary thromboendarterectomy (PTE), a lifesaving surgery to clear the lung's arteries of scar-like tissue that robs ...

Toronto Partnership to Create Fast Diagnostic Tools to Assess Donated Lungs for Transplant - Pulmonary Hypertension News

Toronto Partnership to Create Fast Diagnostic Tools to Assess Donated Lungs for Transplant    Pulmonary Hypertension News SQI Diagnostics and Toronto's University Health Network plan to create rapid diagnostic tools to assess lung suitability for transplant.

Should Macitentan Plus Riociguat Be Used as First-Line Therapy in PAH? - Pulmonology Advisor

Should Macitentan Plus Riociguat Be Used as First-Line Therapy in PAH?    Pulmonology Advisor Upfront combination therapy with macitentan plus riociguat has demonstrated effectiveness in patients with pulmonary arterial hypertension.

4,000th Lifesaving Heart and Lung Surgery at UC San Diego Health - UC San Diego Health

4,000th Lifesaving Heart and Lung Surgery at UC San Diego Health    UC San Diego Health UC San Diego Health performed its 4000th pulmonary thromboendarterectomy (PTE), a lifesaving surgery to clear the lung's arteries of scar-like tissue that robs ...

Toronto Partnership to Create Fast Diagnostic Tools to Assess Donated Lungs for Transplant - Pulmonary Hypertension News

Toronto Partnership to Create Fast Diagnostic Tools to Assess Donated Lungs for Transplant    Pulmonary Hypertension News SQI Diagnostics and Toronto's University Health Network plan to create rapid diagnostic tools to assess lung suitability for transplant.

Should Macitentan Plus Riociguat Be Used as First-Line Therapy in PAH? - Pulmonology Advisor

Should Macitentan Plus Riociguat Be Used as First-Line Therapy in PAH?    Pulmonology Advisor Upfront combination therapy with macitentan plus riociguat has demonstrated effectiveness in patients with pulmonary arterial hypertension.

4,000th Lifesaving Heart and Lung Surgery at UC San Diego Health - UC San Diego Health

4,000th Lifesaving Heart and Lung Surgery at UC San Diego Health    UC San Diego Health UC San Diego Health performed its 4000th pulmonary thromboendarterectomy (PTE), a lifesaving surgery to clear the lung's arteries of scar-like tissue that robs ...

Pulmonary Disease Rates High in Lupus | Medpage Today - MedPage Today

Pulmonary Disease Rates High in Lupus | Medpage Today    MedPage Today Pulmonary complications were common among patients with systemic lupus erythematosus (SLE) and can occur early in the disease course, a Swedish study ...

Generic Version of Adcirca to be Launched in US Under Brand Name ALYQ for PAH - Pulmonary Hypertension News

Generic Version of Adcirca to be Launched in US Under Brand Name ALYQ for PAH    Pulmonary Hypertension News Teva is launching a generic version of Adcirca (tadalafil) in the United States under the brand name ALYQ for the treatment of PAH.

Group Publishes New Guidelines on Home Oxygen Therapy for Kids with PH - Pulmonary Hypertension News

Group Publishes New Guidelines on Home Oxygen Therapy for Kids with PH    Pulmonary Hypertension News The American Thoracic Society issued guidelines for home oxygen therapy to treat chronic hypoxemia in children with pulmonary hypertension.

Early Results on Rodatristat Ethyl Support Launch of Phase 2 Trial in PAH Patients - Pulmonary Hypertension News

Early Results on Rodatristat Ethyl Support Launch of Phase 2 Trial in PAH Patients    Pulmonary Hypertension News Preclinical and early clinical data showing the safety and potential therapeutic activity of rodatristat ethyl support its progression into Phase 2 trials in patients ...

Lung transplantation for idiopathic pulmonary fibrosis - The Lancet

Lung transplantation for idiopathic pulmonary fibrosis    The Lancet Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease with a poor prognosis. Lung transplantation is the only intervention shown to increase life ...

Toronto Partnership to Create Fast Diagnostic Tools to Assess Donated Lungs for Transplant - Pulmonary Hypertension News

Toronto Partnership to Create Fast Diagnostic Tools to Assess Donated Lungs for Transplant    Pulmonary Hypertension News SQI Diagnostics and Toronto's University Health Network plan to create rapid diagnostic tools to assess lung suitability for transplant.

Unnecessary ED visits from chronically ill patients cost $8.3 billion - ModernHealthcare.com

Unnecessary ED visits from chronically ill patients cost $8.3 billion    ModernHealthcare.com Six common chronic conditions accounted for 60% of 24 million ED visits in 2017, and about 30% of those visits—or 4.3 million—were likely preventable and ...

Group Publishes New Guidelines on Home Oxygen Therapy for Kids with PH - Pulmonary Hypertension News

Group Publishes New Guidelines on Home Oxygen Therapy for Kids with PH    Pulmonary Hypertension News The American Thoracic Society issued guidelines for home oxygen therapy to treat chronic hypoxemia in children with pulmonary hypertension.

Early Results on Rodatristat Ethyl Support Launch of Phase 2 Trial in PAH Patients - Pulmonary Hypertension News

Early Results on Rodatristat Ethyl Support Launch of Phase 2 Trial in PAH Patients    Pulmonary Hypertension News Preclinical and early clinical data showing the safety and potential therapeutic activity of rodatristat ethyl support its progression into Phase 2 trials in patients ...

Lung transplantation for idiopathic pulmonary fibrosis - The Lancet

Lung transplantation for idiopathic pulmonary fibrosis    The Lancet Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease with a poor prognosis. Lung transplantation is the only intervention shown to increase life ...

Teva launches generic pulmonary hypertension drug - Globes

Teva launches generic pulmonary hypertension drug    Globes Teva EVP: This launch is an important addition to our portfolio of generic medicines that treat complex conditions.

Toronto Partnership to Create Fast Diagnostic Tools to Assess Donated Lungs for Transplant - Pulmonary Hypertension News

Toronto Partnership to Create Fast Diagnostic Tools to Assess Donated Lungs for Transplant    Pulmonary Hypertension News SQI Diagnostics and Toronto's University Health Network plan to create rapid diagnostic tools to assess lung suitability for transplant.

Investigation: Woman's tragic death among 68 at HRRJ since 2003 - WAVY-TV

Investigation: Woman's tragic death among 68 at HRRJ since 2003    WAVY-TV 10 On Your Side is investigating what changes are being made at Hampton Roads Regional Jail.

Unnecessary ED visits from chronically ill patients cost $8.3 billion - ModernHealthcare.com

Unnecessary ED visits from chronically ill patients cost $8.3 billion    ModernHealthcare.com Six common chronic conditions accounted for 60% of 24 million ED visits in 2017, and about 30% of those visits—or 4.3 million—were likely preventable and ...

FDA cleared a record-breaking 106 medical devices in 2018 - AI in Healthcare

FDA cleared a record-breaking 106 medical devices in 2018    AI in Healthcare It was a record-breaking year for medical device approvals in the FDA, with the government agency approving 106 novel devices in 2018—beating 2017's 99 ...

Group Publishes New Guidelines on Home Oxygen Therapy for Kids with PH - Pulmonary Hypertension News

Group Publishes New Guidelines on Home Oxygen Therapy for Kids with PH    Pulmonary Hypertension News The American Thoracic Society issued guidelines for home oxygen therapy to treat chronic hypoxemia in children with pulmonary hypertension.

Early Results on Rodatristat Ethyl Support Launch of Phase 2 Trial in PAH Patients - Pulmonary Hypertension News

Early Results on Rodatristat Ethyl Support Launch of Phase 2 Trial in PAH Patients    Pulmonary Hypertension News Preclinical and early clinical data showing the safety and potential therapeutic activity of rodatristat ethyl support its progression into Phase 2 trials in patients ...

Lung transplantation for idiopathic pulmonary fibrosis - The Lancet

Lung transplantation for idiopathic pulmonary fibrosis    The Lancet Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease with a poor prognosis. Lung transplantation is the only intervention shown to increase life ...

Toronto Partnership to Create Fast Diagnostic Tools to Assess Donated Lungs for Transplant - Pulmonary Hypertension News

Toronto Partnership to Create Fast Diagnostic Tools to Assess Donated Lungs for Transplant    Pulmonary Hypertension News SQI Diagnostics and Toronto's University Health Network plan to create rapid diagnostic tools to assess lung suitability for transplant.

Unnecessary ED visits from chronically ill patients cost $8.3 billion - ModernHealthcare.com

Unnecessary ED visits from chronically ill patients cost $8.3 billion    ModernHealthcare.com Six common chronic conditions accounted for 60% of 24 million ED visits in 2017, and about 30% of those visits—or 4.3 million—were likely preventable and ...

FDA cleared a record-breaking 106 medical devices in 2018 - AI in Healthcare

FDA cleared a record-breaking 106 medical devices in 2018    AI in Healthcare It was a record-breaking year for medical device approvals in the FDA, with the government agency approving 106 novel devices in 2018—beating 2017's 99 ...

Group Publishes New Guidelines on Home Oxygen Therapy for Kids with PH - Pulmonary Hypertension News

Group Publishes New Guidelines on Home Oxygen Therapy for Kids with PH    Pulmonary Hypertension News The American Thoracic Society issued guidelines for home oxygen therapy to treat chronic hypoxemia in children with pulmonary hypertension.

Early Results on Rodatristat Ethyl Support Launch of Phase 2 Trial in PAH Patients - Pulmonary Hypertension News

Early Results on Rodatristat Ethyl Support Launch of Phase 2 Trial in PAH Patients    Pulmonary Hypertension News Preclinical and early clinical data showing the safety and potential therapeutic activity of rodatristat ethyl support its progression into Phase 2 trials in patients ...

Lung transplantation for idiopathic pulmonary fibrosis - The Lancet

Lung transplantation for idiopathic pulmonary fibrosis    The Lancet Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease with a poor prognosis. Lung transplantation is the only intervention shown to increase life ...

Toronto Partnership to Create Fast Diagnostic Tools to Assess Donated Lungs for Transplant - Pulmonary Hypertension News

Toronto Partnership to Create Fast Diagnostic Tools to Assess Donated Lungs for Transplant    Pulmonary Hypertension News SQI Diagnostics and Toronto's University Health Network plan to create rapid diagnostic tools to assess lung suitability for transplant.

Predicting Treatment Success in Systemic Lupus Erythematosus-Associated PAH - Pulmonology Advisor

Predicting Treatment Success in Systemic Lupus Erythematosus-Associated PAH    Pulmonology Advisor Treatment success in systemic lupus erythematosus-associated pulmonary arterial hypertension (SLE-associated PAH), as defined by the European Society of ...

Unnecessary ED visits from chronically ill patients cost $8.3 billion - ModernHealthcare.com

Unnecessary ED visits from chronically ill patients cost $8.3 billion    ModernHealthcare.com Six common chronic conditions accounted for 60% of 24 million ED visits in 2017, and about 30% of those visits—or 4.3 million—were likely preventable and ...

FDA cleared a record-breaking 106 medical devices in 2018 - AI in Healthcare

FDA cleared a record-breaking 106 medical devices in 2018    AI in Healthcare It was a record-breaking year for medical device approvals in the FDA, with the government agency approving 106 novel devices in 2018—beating 2017's 99 ...

Teva launches generic pulmonary hypertension drug - Globes

Teva launches generic pulmonary hypertension drug    Globes Teva EVP: This launch is an important addition to our portfolio of generic medicines that treat complex conditions.

Toronto Partnership to Create Fast Diagnostic Tools to Assess Donated Lungs for Transplant - Pulmonary Hypertension News

Toronto Partnership to Create Fast Diagnostic Tools to Assess Donated Lungs for Transplant    Pulmonary Hypertension News SQI Diagnostics and Toronto's University Health Network plan to create rapid diagnostic tools to assess lung suitability for transplant.

Should Macitentan Plus Riociguat Be Used as First-Line Therapy in PAH? - Pulmonology Advisor

Should Macitentan Plus Riociguat Be Used as First-Line Therapy in PAH?    Pulmonology Advisor Upfront combination therapy with macitentan plus riociguat has demonstrated effectiveness in patients with pulmonary arterial hypertension.

Teva launches generic pulmonary hypertension drug - Globes

Teva launches generic pulmonary hypertension drug    Globes Teva EVP: This launch is an important addition to our portfolio of generic medicines that treat complex conditions.

Should Macitentan Plus Riociguat Be Used as First-Line Therapy in PAH? - Pulmonology Advisor

Should Macitentan Plus Riociguat Be Used as First-Line Therapy in PAH?    Pulmonology Advisor Upfront combination therapy with macitentan plus riociguat has demonstrated effectiveness in patients with pulmonary arterial hypertension.

4,000th Lifesaving Heart and Lung Surgery at UC San Diego Health - UC San Diego Health

4,000th Lifesaving Heart and Lung Surgery at UC San Diego Health    UC San Diego Health UC San Diego Health performed its 4000th pulmonary thromboendarterectomy (PTE), a lifesaving surgery to clear the lung's arteries of scar-like tissue that robs ...

Should Macitentan Plus Riociguat Be Used as First-Line Therapy in PAH? - Pulmonology Advisor

Should Macitentan Plus Riociguat Be Used as First-Line Therapy in PAH?    Pulmonology Advisor Upfront combination therapy with macitentan plus riociguat has demonstrated effectiveness in patients with pulmonary arterial hypertension.

4,000th Lifesaving Heart and Lung Surgery at UC San Diego Health - UC San Diego Health

4,000th Lifesaving Heart and Lung Surgery at UC San Diego Health    UC San Diego Health UC San Diego Health performed its 4000th pulmonary thromboendarterectomy (PTE), a lifesaving surgery to clear the lung's arteries of scar-like tissue that robs ...

Reduced Right Ventricular Output Reserve Observed in SSc With Elevated PAP - Rheumatology Advisor

Reduced Right Ventricular Output Reserve Observed in SSc With Elevated PAP    Rheumatology Advisor Investigators examined right ventricular function and pulmonary arterial compliance at rest and during exercise in patients with systemic sclerosis with normal or ...

Should Macitentan Plus Riociguat Be Used as First-Line Therapy in PAH? - Pulmonology Advisor

Should Macitentan Plus Riociguat Be Used as First-Line Therapy in PAH?    Pulmonology Advisor Upfront combination therapy with macitentan plus riociguat has demonstrated effectiveness in patients with pulmonary arterial hypertension.

4,000th Lifesaving Heart and Lung Surgery at UC San Diego Health - UC San Diego Health

4,000th Lifesaving Heart and Lung Surgery at UC San Diego Health    UC San Diego Health UC San Diego Health performed its 4000th pulmonary thromboendarterectomy (PTE), a lifesaving surgery to clear the lung's arteries of scar-like tissue that robs ...

Should Macitentan Plus Riociguat Be Used as First-Line Therapy in PAH? - Pulmonology Advisor

Should Macitentan Plus Riociguat Be Used as First-Line Therapy in PAH?    Pulmonology Advisor Upfront combination therapy with macitentan plus riociguat has demonstrated effectiveness in patients with pulmonary arterial hypertension.

4,000th Lifesaving Heart and Lung Surgery at UC San Diego Health - UC San Diego Health

4,000th Lifesaving Heart and Lung Surgery at UC San Diego Health    UC San Diego Health UC San Diego Health performed its 4000th pulmonary thromboendarterectomy (PTE), a lifesaving surgery to clear the lung's arteries of scar-like tissue that robs ...

Should Macitentan Plus Riociguat Be Used as First-Line Therapy in PAH? - Pulmonology Advisor

Should Macitentan Plus Riociguat Be Used as First-Line Therapy in PAH?    Pulmonology Advisor Upfront combination therapy with macitentan plus riociguat has demonstrated effectiveness in patients with pulmonary arterial hypertension.

4,000th Lifesaving Heart and Lung Surgery at UC San Diego Health - UC San Diego Health

4,000th Lifesaving Heart and Lung Surgery at UC San Diego Health    UC San Diego Health UC San Diego Health performed its 4000th pulmonary thromboendarterectomy (PTE), a lifesaving surgery to clear the lung's arteries of scar-like tissue that robs ...

Should Macitentan Plus Riociguat Be Used as First-Line Therapy in PAH? - Pulmonology Advisor

Should Macitentan Plus Riociguat Be Used as First-Line Therapy in PAH?    Pulmonology Advisor Upfront combination therapy with macitentan plus riociguat has demonstrated effectiveness in patients with pulmonary arterial hypertension.

4,000th Lifesaving Heart and Lung Surgery at UC San Diego Health - UC San Diego Health

4,000th Lifesaving Heart and Lung Surgery at UC San Diego Health    UC San Diego Health UC San Diego Health performed its 4000th pulmonary thromboendarterectomy (PTE), a lifesaving surgery to clear the lung's arteries of scar-like tissue that robs ...

Should Macitentan Plus Riociguat Be Used as First-Line Therapy in PAH? - Pulmonology Advisor

Should Macitentan Plus Riociguat Be Used as First-Line Therapy in PAH?    Pulmonology Advisor Upfront combination therapy with macitentan plus riociguat has demonstrated effectiveness in patients with pulmonary arterial hypertension.

4,000th Lifesaving Heart and Lung Surgery at UC San Diego Health - UC San Diego Health

4,000th Lifesaving Heart and Lung Surgery at UC San Diego Health    UC San Diego Health UC San Diego Health performed its 4000th pulmonary thromboendarterectomy (PTE), a lifesaving surgery to clear the lung's arteries of scar-like tissue that robs ...

Should Macitentan Plus Riociguat Be Used as First-Line Therapy in PAH? - Pulmonology Advisor

Should Macitentan Plus Riociguat Be Used as First-Line Therapy in PAH?    Pulmonology Advisor Upfront combination therapy with macitentan plus riociguat has demonstrated effectiveness in patients with pulmonary arterial hypertension.

4,000th Lifesaving Heart and Lung Surgery at UC San Diego Health - UC San Diego Health

4,000th Lifesaving Heart and Lung Surgery at UC San Diego Health    UC San Diego Health UC San Diego Health performed its 4000th pulmonary thromboendarterectomy (PTE), a lifesaving surgery to clear the lung's arteries of scar-like tissue that robs ...

Lung transplantation for idiopathic pulmonary fibrosis - The Lancet

Lung transplantation for idiopathic pulmonary fibrosis    The Lancet Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease with a poor prognosis. Lung transplantation is the only intervention shown to increase life ...

Should Macitentan Plus Riociguat Be Used as First-Line Therapy in PAH? - Pulmonology Advisor

Should Macitentan Plus Riociguat Be Used as First-Line Therapy in PAH?    Pulmonology Advisor Upfront combination therapy with macitentan plus riociguat has demonstrated effectiveness in patients with pulmonary arterial hypertension.

Lung transplantation for idiopathic pulmonary fibrosis - The Lancet

Lung transplantation for idiopathic pulmonary fibrosis    The Lancet Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease with a poor prognosis. Lung transplantation is the only intervention shown to increase life ...

Should Macitentan Plus Riociguat Be Used as First-Line Therapy in PAH? - Pulmonology Advisor

Should Macitentan Plus Riociguat Be Used as First-Line Therapy in PAH?    Pulmonology Advisor Upfront combination therapy with macitentan plus riociguat has demonstrated effectiveness in patients with pulmonary arterial hypertension.

Lung transplantation for idiopathic pulmonary fibrosis - The Lancet

Lung transplantation for idiopathic pulmonary fibrosis    The Lancet Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease with a poor prognosis. Lung transplantation is the only intervention shown to increase life ...